Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangzhengxiaoji Capsule with Chemotherapy in Advanced NSCLC
NCT02195453Phase 4Unknown
- Sponsor
- Shandong Cancer Hospital
- Start
- Aug 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of yangzheng xiaoji capsule in non-small cell lung cancer (NSCLC), sponsored by Shandong Cancer Hospital. Status: unknown.
02
Drugs
yangzheng xiaoji capsule
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02195453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195453.